Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

Oppenheimer Asset Management Inc. lessened its position in Invesco S&P 500 High Beta ETF (NYSEARCA:SPHB – Free Report) by ...

Oppenheimer Asset Management Inc. reduced its holdings in MDU Resources Group, Inc. (NYSE:MDU – Free Report) by 5.1% in the ...

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...

This is the story of Robert Oppenheimer, father of the atomic bomb. A brilliant man marred by pain and suffering. As tragic as some parts are, his life can teach us some valuable lessons.

David Krumholtz unfortunately developed a rare and extremely dangerous disease, and he feels the need to publicly alert ...

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer analyst Jay Olson lowered the firm’s price target on Denali Therapeutics (DNLI) to $42 from $50 and keeps an Outperform rating on the shares following quarterly results and after hosting ...

The audience for the highest honors in Hollywood fell 7% from the 2024 ceremony, when 19.5 million people tuned in to see ...